I

INIFY Laboratories AB
OSE:INIFY

Watchlist Manager
INIFY Laboratories AB
OSE:INIFY
Watchlist
Price: 3.5 NOK -27.08% Market Closed
Market Cap: 276.2m NOK

INIFY Laboratories AB
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

INIFY Laboratories AB
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
I
INIFY Laboratories AB
OSE:INIFY
EPS (Diluted)
-kr1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medicover AB
STO:MCOV B
EPS (Diluted)
€0
CAGR 3-Years
-46%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Dedicare AB (publ)
STO:DEDI
EPS (Diluted)
kr4
CAGR 3-Years
-24%
CAGR 5-Years
7%
CAGR 10-Years
-4%
NGS Group AB
STO:NGS
EPS (Diluted)
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hedera Group AB (publ)
STO:HEGR
EPS (Diluted)
kr0
CAGR 3-Years
N/A
CAGR 5-Years
18%
CAGR 10-Years
37%
No Stocks Found

INIFY Laboratories AB
Glance View

Market Cap
276.2m NOK
Industry
Health Care

INIFY Laboratories AB engages in the provision of cancer diagnostics through laboratory services within pathology. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2022-06-20. The firm uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The firm origins from ContextVision.

INIFY Intrinsic Value
0.07 NOK
Overvaluation 98%
Intrinsic Value
Price
I

See Also

What is INIFY Laboratories AB's EPS (Diluted)?
EPS (Diluted)
-1.1 SEK

Based on the financial report for Dec 31, 2024, INIFY Laboratories AB's EPS (Diluted) amounts to -1.1 SEK.

What is INIFY Laboratories AB's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
3%

Over the last year, the EPS (Diluted) growth was 3%.

Back to Top